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Background: General practitioners (GPs) are involved in the management of most melanocytic skin lesions in
Australia. A high quality biopsy technique is a crucial first step in management, as it is recognized that poor
techniques can mislead, delay, or miss a diagnosis of melanoma. There has been little published on the biopsy
decisions and techniques of GPs. This study aims to describe the current management choices made by GPs for
suspicious melanocytic skin lesions and to compare their choices with the best practice guidelines.
Methods: An anonymous survey of GPs presented with three clinical scenarios with increasing complexity of
melanoma in which a referral or biopsy decision was specified.
Results: 391 mailed surveys with a 76.3% response rate. Mean biopsy experience was 4.14 biopsies per GP per
month. The rates of choosing to refer among the three scenarios were 31%, 52% and 81% respectively, with referral
to surgery being the most common choice (81%). Most biopsy techniques (55%) were chosen according to best
practice guidelines, although non-guideline biopsy techniques chosen included shave (n = 10), punch biopsy
(n = 57), wide excisions (n = 65), and flaps (n = 10). The few GPs (n = 5) who identified themselves as skin specialist
GPs were no more likely to adhere to guidelines than their colleagues.
Conclusion: A majority of referrals and biopsies were chosen by GPs according to best practice guidelines, but
concern remains for the high proportion of GPs making non-guideline based choices. How GPs choose to biopsy
or refer needs further training, audit, and research if Australia is to improve the outcome of melanoma
management in general practice.
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Melanoma remains the most common cancer in the 30-51
year old age group and accounts for 3.9% of all cancer deaths
in Australia [1]. The current 5 year survival rate is 92%, a
statistic which relies in part on the early detection and accur-
ate diagnosis of suspicious melanocytic lesions [1].
The general practitioner (GP) is the first point of med-
ical contact for the majority of patients who have suspi-
cious skin lesions in Australia [2,3]. Previous research
has explored the initial step in the diagnostic process –
the assessment of skin lesions presented by patients
[4,5]. The next step is to choose either to biopsy the le-
sion or to refer. A biopsy of melanocytic skin lesions is
crucial as pathological determination of tumour depth* Correspondence: robison.sean@gmail.com
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reproduction in any medium, provided the orinfluences management and prognosis. Furthermore,
poor biopsy techniques can mislead, delay, or miss a
diagnosis of melanoma [6]. A few studies have reviewed
biopsy margins achieved by GPs [7-9], but none have
examined how GPs choose to refer or biopsy when pre-
sented with suspicious melanocytic lesions.
The management of melanoma has been outlined in
recommended guidelines. Commonly accessed sources
of guidelines are the Australian National Health and
Medical Research Council (NHMRC) melanoma guide-
lines [10]. These guidelines have specific comments on
when doctors should biopsy and when to refer for a
range of melanoma sub-types. Retrospective reviews of
the histopathology and biopsy type of confirmed mela-
nomas have focused on the clinical practice of predom-
inantly dermatologists and surgeons [8,11,12], rather
than focusing on GPs.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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or refer suspicious melanocytic skin lesions, and to com-
pare their choices with best practice guidelines.Methods
Subjects
In September 2008 a questionnaire was sent to 391 GPs
from the urban Australian Capital Territory (ACT) region.Questionnaire design
The anonymous questionnaire consisted of three clinical
scenarios of increasing complexity of suspicious melano-
cytic skin lesions and closed questions about the GPs’
choice to refer or biopsy in each scenario as shown in
Table 1.
In each of the scenarios, it was clearly stated that melan-
oma was the provisional diagnosis. A lesion description,
rather than a photo, was employed because the study
sought a choice of management action instead of focusing
on the clinical diagnosis of a specific skin lesion.
In each scenario, the first question asked if the GP
would refer or perform a biopsy. The second question
asked to whom the referral would be made. The third
question asked which kind of biopsy technique would be
chosen (biopsy options were indicated and other sugges-
tions optional). Questions on GPs’ work practices and
whether they had any formal training in dermoscopy or
skin biopsy techniques were also asked.
Results were analysed using SPSS and, where appropri-
ate, the Chi squared ([2] test compared differences be-
tween categories. A content analysis was done of the
responses to the open-ended questions in order to iden-
tify themes. There was one reminder letter sent, and
then one month later the remaining non-responding
GPs were sent a reminder fax.Table 1 Scenarios
SCENARIO 1 On routine examination you notice a 1cm suspicious
pigmented melanocytic lesion on a patient’s mid-back.
You are concerned about the possibility of melanoma.
There is plenty of redundant skin in the area.
SCENARIO 2 A patient complains to you about an itchy lesion on
the ankle. There is a 5mm lesion, which you think may
be melanoma. You judge complete removal of the lesion
with primary closure just possible. Foot pulses are present.
SCENARIO 3 A patient claims that a large area of pigmentation on her
cheek has recently changed colour. Clinically she has a
Hutchinson’s melanotic freckle. You think it may be a
melanoma. It measures 2 x 1cm and complete removal
would probably need a flap.
FOR EACH SCENARIO:*
Question 1 - what is your next action?
Question 2 - if you chose to refer, where would you refer?
Questions 3 - if you do the biopsy yourself, please indicate your technique?
*The list of closed options for biopsy techniques are detailed in results section
Table 2.Adherence to guidelines
The NHMRC clinical practice guidelines for the man-
agement of melanoma were used as the benchmark for
classifying whether a GP adhered to guidelines for each
scenario [10]. The 1999 version of the guidelines were
used, as the study period concluded at the time of the
2008 updated guideline release [13]. In order to limit po-
tential response bias, the GPs were not asked if they
were aware of the NHMRC guidelines. The list of eight
possible biopsy types is shown in Table 2. In the first
two scenarios, a GP was classified as having adhered to
the guideline if the GP chose to refer or to perform an
excision biopsy with 1-2 mm margins. In the third sce-
nario, a GP was classified as having adhered to the
guideline if, and only if, the GP chose to refer.
Ethical approval was obtained from the Australian Na-
tional University Human Ethics Committee and the
ACT Health Human Research Ethics Committee.Results
Response
Of the 391 people contacted, 299 responded to the sur-
vey (76.3%) of which 285 (72.7%) were included for data
analysis. Excluded responses included retired GPs or
those not located at a general practice. Among the
responders, 87 GPs (29%) worked part-time in general
practice, and 20 GPs (7%) worked in a specialized area
of general practice, of which five worked in skin cancer
management.Clinical experience
The reported mean number (SD) of biopsies performed
in clinical practice by 239 GPs was 4.14 (8.65) biopsies
per month. The range was 0 to 70 biopsies per month
with 221 GPs (92.5%) performing up to 10 biopsies per
month, and 56 GPs (20%) reported none. Fewer GPs
(142, 48%) reported routine use of dermoscopy in clin-
ical practice. The five GPs who specialized in skin cancer
management performed a mean of 44.80 (17.68) biopsies
per month, and all routinely used dermoscopy.Training
More GPs (132, 44%) reported receiving formal training in
skin biopsy techniques, than formal training in dermo-
scopy (81, 27%). There was no difference in the proportion
of part-time GPs who had formal training in dermoscopy
compared to full-time GPs (p= 0.278), however, signifi-
cantly fewer part-time GPs had formal training in biopsy
techniques compared to full-time GPs (42% versus 62%, χ2
test = 8.175, df =1, p = 0.004). All five GPs who specialised
in skin cancer management had formal training in both
dermoscopy and biopsy techniques.
Table 2 Referrals and biopsy techniques chosen by 285 general practitioners for three clinical scenarios of patients
presenting with suspicious melanocytic lesion
Response Scenario 1 Scenario 2 Scenario 3
Total Number 285 285 285
Missing choice data 1 0 17
GP chooses* to refer 89 31% 147 52% 231 81%
Another GP 30 31% 30 18% 13 6%
A dermatologist 22 21% 34 20% 35 15%
A general surgeon 24 25% 55 32% 37 16%
A plastics surgeon 22 21% 51 30% 151 64%
Missing referral data 10 10 19
GP chooses to biopsy 195 68% 138 48% 37 14%
A shave biopsy 2 1% 3 2% 5 14%
An incisional punch biopsy (2-4mm diameter) 17 9% 18 13% 22 61%
An incisional biopsy 1 0.5% 3 2% 5 14%
An excision biopsy 1-2 mm margins** 97 50% 72 53% NA
An excision biopsy 5-10 mm margins 52 27% 13 9% NA
An excision biopsy (1-2 mm margin) with primary closure NA NA 1 3%
An excision biopsy (1-2 mm margin) with a flap NA 3 2% 4 11%
Other 1 0.5% 1 0.5% 0 0%
Missing biopsy data 25 13% 25 18% 0 0%
Adheres to guidelines# 186 65% 219 77% 231 86%
* GPs could choose more than one kind of referral.
** Biopsy technique suggested in 1999 Guideline.
NA – Indicates that choice of biopsy technique not given in the scenario.
# Combined referral and 1999 Guideline.
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There were 285 GPs who chose to refer, among whom
83 GPs (29%) referred in all three scenarios, 61 GPs
(21%) referred in two scenarios, 94 GPs (33%) referred
in only one scenario, and 45 GPs (16%) referred none.
Table 2 shows that the referral rates for the three sce-
narios were 31%, 52%, and 81% respectively. More part-
time GPs referred in one or more scenarios compared
to full-time GPs (93% versus 85%, χ2 test = 16.503,
df =3, p = 0.001), and similarly, more GPs without
training in biopsy techniques referred in one or more
scenarios compared to GPs who did have training (97%
versus 81%, χ2 test = 22.555, df =3, p = 0.0001). None
of the five GPs who specialised in skin cancer manage-
ment referred in any scenario.
There were 428 instances where referral to a specialist
was chosen. In 224 instances (44%) referrals were made
to plastics surgeons, 116 referrals (23%) to general sur-
geons, 91 referrals (18%) to dermatologists, and 73 refer-
rals (15%) to other GPs who did biopsies.
There were 239 GPs who indicated they would refer in
one or more scenario, among whom 52 GPs (18%) re-
ferred to more than one kind of specialist. There were
49 GPs who referred at least one scenario to another GP
and 55 GPs had another GP within their general practicewho performed biopsies. More GPs referred patients to
another GP if there was a GP within the practice who
performed biopsies compared to practices that did not
have another GP who performed biopsies (50% versus
30%, χ2 test = 4.043, df =1, p = 0.044).The choice of biopsy technique
Table 2 shows the biopsy rates for the scenarios were
68%, 48%, and 14% respectively. There were 29 GPs
(10%) who chose to biopsy in all three scenarios, 111
GPs (39%) chose to biopsy in two scenarios, 61 GPs
(21%) chose to biopsy in one scenario only, and 84 GPs
(30%) chose to biopsy in none. More full-time GPs chose
to biopsy in one or more scenario compared to part-
time GPs (77% versus 61%, χ2 test = 17.460, df =3,
p = 0.001). More GPs with training in biopsy techniques
chose to biopsy in one or more scenarios compared to
GPs who did not have training (80% versus 60%, χ2 test =
21.606, df =3, p = 0.0001). All five GPs who specialised
in skin cancer management chose to biopsy in all three
scenarios.
Table 3 shows GP’s comments reporting why they
chose not to perform a biopsy in one or more of the sce-
narios. There was no significant variation in these
Table 3 Reasons why 156 general practitioners did not
perform a biopsy in one or more scenarios of patients
presenting with suspicious melanocytic lesions
Reason for not performing a biopsy Positive response %
You do not feel comfortable
doing the biopsy
101 60%
You have no interest in performing
any biopsies
21 13%
Your surgery is not equipped for this 8 5%
Other comments: 38 23%
Qualitative analysis of
other specified comments*:
Biopsy requires an expert
“If it is melanoma it needs specialist care”
“It may not need a biopsy if a dermatologist looks at it”
“The other GP in our practice does biopsies”
Difficulty with biopsy technique
“Clinical melanoma needs a wide local excision”
“I prefer not to excise cosmetically sensitive areas”
Personal issues
“I have arthritic fingers”
“I do not excise from the face”
Systems issues
“Doing biopsy is time consuming - not well remunerated”
“There are medico legal risks with doing facial lesions”
“There is more co-coordinated care for referrals”
*GP could have more than one comment.
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training in biopsy techniques.
Adherence to the 1999 clinical practice guidelines for the
management of melanoma
The correct choice recommended by the guidelines to
perform “An excision biopsy 1-2 mm margins” was
taken in 169 instances (55%). Table 2 shows the adher-
ence rates to guidelines for each of the three scenarios
were 65%, 77%, and 86% respectively.
In the first scenario, there was no significant relation-
ship between adherence to guidelines and formal train-
ing in dermoscopy (p = 0.532). In the second scenario,
more GPs with formal training in dermoscopy adhered
to guidelines compared to GPs who did not adhere (49%
versus 27% χ2 test = 5.279, df =1, p = 0.022). In the third
scenario, more GPs with formal training in dermoscopy
did not adhere to guidelines compared to GPs who did
adhere (71% versus 40% χ2 test = 9.814, df = 1, p = 0.002).
In the first two scenarios, there was no significant rela-
tionship between adherence to guidelines and formal
training in biopsy techniques (p = 0.199 and p = 0.354 re-
spectively). In the third scenario more GPs with formal
training in biopsy techniques did not adhere toguidelines compared to GPs who did not have training
(86% versus 49%, χ2 test = 16.019, df =1, p = 0.000).
Completion of all three scenarios was done by 267
GPs, among whom 153 GPs (54%) adhered to guidelines
in all three scenarios, 70 GPs (25%) adhered in two sce-
narios, 33 GPs (12%) adhered in one scenario, and 11
GPs (4%) adhered in none. Table 4 shows the character-
istics of GPs and the number of scenarios where GPs
demonstrated adherence to guidelines. More GPs
demonstrated adherence in none and two scenarios if
they had any training (p = 0.001), routinely used dermo-
scopy (p = 0.002), and had a higher clinical biopsy rate
(p = 0.001). Paradoxically, fewer GPs demonstrated ad-
herence in one and three scenarios for these
characteristics.
Discussion
This study demonstrates that a majority of GPs in the
ACT adhere to best practice guidelines for suspicious
melanocytic lesions by choosing to refer for a specialist
opinion where appropriate (in 54% of instances) – the
safest option suggested by best practice guidelines in
1999 [10]. In this study, most referrals were to general
surgeons, plastic surgeons and dermatologists. However,
17% of referrals were to other GPs, particularly if the GP
who performed biopsies worked within the referring
GP’s general practice. In 18% of scenarios, GPs chose to
refer cases to more than one specialist. Comments from
these respondents indicated a frustration with extended
waiting times for specialist care, and a need for multiple
referrals in order to maximize the chances of an earlier
assessment. Although this study reflects the availability
of local services in the ACT region, specialists in general
may acknowledge potential access issues and consider
more streamlined approaches to assessment and
management.
The majority of GPs (84%) chose to perform a biopsy
in one or more scenarios and most GPs (55%) chose the
guideline recommended biopsy technique of an excision
biopsy with 1-2 mm margin for scenarios one and two.
Concern exists for the remaining non-guideline biopsy
techniques chosen because of the inherent risks asso-
ciated with them. In this study, there were 66 scenarios
(21% of all choices to biopsy) where incisional or punch
biopsies were chosen. The risks associated with these
techniques include sampling error, missing active inva-
sive melanoma, and creating an area of fibrosis in the
remaining tissue, which may confuse the pathology in
further excisions [9,11,14]. There were 65 instances
(21%) where large diameter biopsies were chosen. This
technique would obtain a sufficient margin around a
melanotic lesion, but may result in unnecessary cosmetic
disfigurement – an important element considering the
number needed to treat (NNT) melanoma ranges from
Table 4 The characteristics of GPs and their adherence to guidelines for up to three scenarios of patients presenting
with suspicious melanocytic lesions
GP characteristic Number of GPs Number of scenarios where GPs adhered to guidelines
None of the Scenarios One Scenario Two Scenarios Three Scenarios
Training*
Dermoscopy only 19 0 0% 1 5% 7 37% 11 58%
Biopsy only 69 4 6% 6 9% 25 36% 34 49%
Trained in both 62 5 8% 5 8% 21 34% 31 50%
No training 94 1 1% 11 12% 17 18% 65 69%
Full-time** 137 6 4% 18 13% 38 28% 75 56%
Part-time 86 3 3% 5 6% 22 22% 56 56%
GP specialises in skin cancer management 5 1 0 4 0
Routine use of dermoscopy# 7 78% 13 57% 52 74% 62 49%
Mean (SD) biopsies per month## 8.50 (8.11) 3.30 (3.47) 8.21 (14.37) 1.98 (2.86)
*(n = 242 GPs, χ2 test = 43.238, df =12, p = 0.000).
**(Mann-Whitney U test, n = 242 GPs, z = -1.72, p = 0.085).
# (Mann-Whitney U test, n = 223 GPs, z = -3.076, p = 0.002).
## (One-way ANOVA, n = 237 GPs, df = 3, F = 9.657, p < 0.01).
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[15]. A wider margin could also compromise further ex-
cision and alter the lymphatic drainage, potentially
impacting on future sentinel node mapping. There were
10 scenarios (3%) where shave biopsies were chosen, a
technique that has been shown to poorly identify
tumour depth, limiting accurate staging of the melan-
oma lesion [11]. Shave biopsy may sample an area of re-
gression where melanoma has invaded below the shave,
or an area of invasion that is clinically inconspicuous
[11,16]. Furthermore, a recent study in Australia has
highlighted the increased rates of misdiagnosed melan-
oma histopathology with the use of shave and punch bi-
opsies, when compared to excisional biopsy [17]. Finally,
in seven scenarios (2%) skin flaps were chosen with exci-
sion biopsies. Researchers have identified an increasing
trend in general practice towards the use of flaps, par-
ticularly in skin cancer clinics [3]. Performing flaps with-
out a histological confirmation of margins can confuse
re-excision because the remaining margins have been
altered, requiring more extensive and complex definitive
excision. Non-guideline techniques may ultimately com-
promise a timely diagnosis.
Characteristics of the GP had a profound impact on
both the decision to refer and the choice of biopsy tech-
nique. Part-time GPs were less likely to train in dermo-
scopy or biopsy techniques and were more likely to refer
than their full-time colleagues. Conversely, GPs who
worked full-time had more experience of biopsy in their
clinical practices and were more likely to choose to bi-
opsy in the scenarios. Finally, the few GPs who identified
themselves as specialists in skin cancer management did
not refer any cases to other specialists and performed
four times more biopsies per month than theircolleagues - yet paradoxically they were no more likely
to adhere to guidelines than their colleagues.
The frequent use of non-guideline biopsy techniques
in this study supports the argument for further training
of GPs in melanoma management. Numerous studies
recognize that targeted training has a variable impact on
identification and NNT of melanoma [4,18,19]. This
study confirms the mixed effect on guideline adherence
following training, suggesting that the type of training
done in the past may not be sufficient. For example, ra-
ther than GPs train by going to formal courses away
from their place of work, perhaps improved feedback
mechanisms at the time of biopsy may improve adher-
ence to guidelines. This feedback could come in the
form of regular clinical audit of the GP’s pathology
results and their adherence with guidelines. An example
of a current audit system is the Skin Cancer College of
Australia and New Zealand Skin Cancer Audit Research
Database (www.skincanceraudit.com). Future research
on how GPs might improve adherence to guidelines is
needed.
This study was limited in that we provided only three
written scenarios, and analyzed the actions GPs stated
they would perform in a theoretical context, rather than
analyse their actual clinical behavior. The use of the
term ‘may’ in the scenarios could have introduced ambi-
guity in the strength of GP responses. The referral pat-
terns we observed may have reflected the availability of
local surgical services. This study did not assess the in-
fluence of private health insurance on GP decisions to
refer or biopsy. The low rate of adherence in scenario
three might reflect the change over time in the guideline
advice from generalized to specialized approaches in the
management of lentigo maligna melanoma (LMM) [10].
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approach to LMM management in general practice. An-
other consideration is that the circulation of the draft
2008 NHMRC melanoma guidelines coincided with the
conclusion of our study and may have biased a limited
number of late responders [13].
Conclusion
A majority of referrals and biopsies were chosen by GPs
according to best practice guidelines, but concern
remains for the high proportion of GPs making non-
guideline based choices. Further training, audit, and re-
search on how GPs choose to biopsy or refer needs to
be considered if Australia is to improve the outcome of
melanoma management in general practice.
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